Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia

PURPOSE: Phase 1 clinical trials have established low-dose, whole-lung radiation therapy (LD-RT) as safe for patients with coronavirus disease 2019 (COVID-19)-related pneumonia. By focally dampening cytokine hyperactivation, LD-RT may improve disease outcomes through immunomodulation. METHODS AND MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Hess, Clayton B., Nasti, Tahseen H., Dhere, Vishal R., Kleber, Troy J., Switchenko, Jeffrey M., Buchwald, Zachary S., Stokes, William A., Weinberg, Brent D., Rouphael, Nadine, Steinberg, James P., Godette, Karen D., Murphy, David J., Ahmed, Rafi, Curran, Walter J., Khan, Mohammad K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
COVID-19 Scientific Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832642/
https://www.ncbi.nlm.nih.gov/pubmed/33340603
http://dx.doi.org/10.1016/j.ijrobp.2020.12.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832642/
https://www.ncbi.nlm.nih.gov/pubmed/33340603
http://dx.doi.org/10.1016/j.ijrobp.2020.12.011

Ejemplares similares